BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6757576)

  • 1. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-drug therapy in leprosy.
    Girdhar BK
    Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 4. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 5. [New trends in the treatment of leprosy].
    Koźmińska-Kubarska A
    Pol Tyg Lek; 1983 Nov; 38(46):1439-41. PubMed ID: 6374636
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for chemotherapy of leprosy.
    Ji B
    Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H
    Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
    [No Abstract]   [Full Text] [Related]  

  • 8. Concepts behind the development of multiple drug therapy regimens in leprosy.
    Waters MF
    Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in the chemotherapy of leprosy.
    Freerksen E
    Lepr India; 1983 Jan; 55(1):122-32. PubMed ID: 6348410
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug therapy (MDT) and leprosy control.
    Noordeen SK
    Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress in the chemotherapy of leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
    [No Abstract]   [Full Text] [Related]  

  • 12. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance in leprosy.
    Ghosh S
    Indian J Dermatol; 1980 Jul; 25(3):1-4. PubMed ID: 7026426
    [No Abstract]   [Full Text] [Related]  

  • 15. The difficult decision when to discontinue multidrug therapy in leprosy.
    Kato L
    Acta Leprol; 1987; 5(4):279-82. PubMed ID: 3327350
    [No Abstract]   [Full Text] [Related]  

  • 16. Concepts behind the development of multiple drug therapy regimens in leprosy.
    Waters MF
    Ethiop Med J; 1986 Dec; 24 Suppl 1():61-7. PubMed ID: 3301333
    [No Abstract]   [Full Text] [Related]  

  • 17. Problems of multidrug therapy.
    Ramu G
    Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
    [No Abstract]   [Full Text] [Related]  

  • 18. The chemotherapy of leprosy. Part 2.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319
    [No Abstract]   [Full Text] [Related]  

  • 19. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 20. Whither short-course chemotherapy for leprosy?
    Grosset J
    Indian J Lepr; 1997; 69(2):119-20. PubMed ID: 9290962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.